Wallis, Robert S.

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

Boeree, M. J., Heinrich, N., Aarnoutse, R., Diacon, A. H., Dawson, R., Rehal, S., Kibiki, G. S., Churchyard, G., Sanne, I., Ntinginya, N. E., et al. (2017) · The Lancet Infectious Diseases

Tuberculosis Research and EpidemiologyInfectious Diseases and Tuberculosis

Cited by 379

Advancing host-directed therapy for tuberculosis

Wallis, R. S., & Hafner, R. (2015) · Nature Reviews Immunology

Tuberculosis Research and EpidemiologyImmune responses and vaccinations

Cited by 291

Reconsidering Adjuvant Immunotherapy for Tuberculosis

Wallis, R. S. (2005) · Clinical Infectious Diseases

Tuberculosis Research and EpidemiologyInfectious Diseases and Tuberculosis

Cited by 121